Skip to main content

Edgestream Partners, L.P.

SEC CIK
0001535061
Latest filing
Aug 11, 2026

ABT holding history

Abbott Laboratories in every 13F filed by Edgestream Partners, L.P., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ABT overviewAll 13F holders of ABTFull Q2 2026 holdings

Shares (Q2 2026)
60,361
Value
$5.48M
% of portfolio
0.2%
Quarters held
20
Since Q1 2021
Holdings of ABT by Edgestream Partners, L.P., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202660,361$5.48M0.2%+56,405+1,425.8%AddedHolders
Q1 20263,956$406.2K<0.1%−13,198−76.9%ReducedHolders
Q4 202517,154$2.15M0.1%+17,154NewHolders
Q3 20250$00.0%−2,971−100.0%Sold outHolders
Q2 20252,971$404.1K<0.1%+2,971NewHolders
Q1 20250$00.0%−3,492−100.0%Sold outHolders
Q4 20243,492$395.0K<0.1%−12,801−78.6%ReducedHolders
Q3 202416,293$1.86M0.1%+306+1.9%AddedHolders
Q2 202415,987$1.66M0.1%+13,353+506.9%AddedHolders
Q1 20242,634$299.4K<0.1%−27,110−91.1%ReducedHolders
Q4 202329,744$3.27M0.2%+17,155+136.3%AddedHolders
Q3 202312,589$1.22M0.1%−8,435−40.1%ReducedHolders
Q2 202321,024$2.29M0.2%−30,636−59.3%ReducedHolders
Q1 202351,660$5.23M0.6%+16,556+47.2%AddedHolders
Q4 202235,104$3.85M0.4%+32,923+1,509.5%AddedHolders
Q3 20222,181$211.0K<0.1%−17,857−89.1%ReducedHolders
Q2 202220,038$2.18M0.2%−8,344−29.4%ReducedHolders
Q1 202228,382$3.36M0.3%+16,476+138.4%AddedHolders
Q4 202111,906$1.68M0.1%−2,177−15.5%ReducedHolders
Q3 202114,083$1.66M0.1%−25,795−64.7%ReducedHolders
Q2 202139,878$4.62M0.3%−3,568−8.2%ReducedHolders
Q1 202143,446$5.21M0.3%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.